- ►asnjournals.org WM McClellan, WD Flanders, RD Langston, C … - Journal of the American Society of Nephrology, 2002 - Am Soc Nephrol ABSTRACT. The purpose of this retrospective cohort study was to examine the
associations among chronic kidney disease, anemia, and risk of death among
patients with heart failure. Retrospective cohort study. Patients with a ... Cited by 292 - Related articles - BL Direct - All 6 versions
DS Rao, M Shih, R Mohini - The New England journal of medicine, 1993 - nejm.highwire.org Background and Methods Anemia is common in patients with chronic renal
insufficiency and secondary hyperparathyroidism. Erythropoietin therapy is
effective, but the dose required varies greatly. One possible determinant ... Cited by 219 - Related articles - BL Direct - All 5 versions
WD Labonia - American Journal of Kidney Diseases, 1995 - Elsevier To demonstrate whether -carnitine treatment could further improve the anemia in
dialyzed patients under recombinant human erythropoietin (r-HuEPO) therapy,
leading to a reduction in r-HuEPO requirements, -carnitine (1 g ... Cited by 115 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org CT Jurkovitz, JL Abramson, LV Vaccarino, … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol Cardiovascular disease (CVD) mortality rates in ESRD are approximately 15 times
higher than in the general population (1). Many studies examining the
association between ESRD and cardiovascular mortality (2,3) have found that ... Cited by 110 - Related articles - BL Direct - All 6 versions
L Kramer, C Madl, F Stockenhuber, W … - Kidney international, 1996 - nature.com Beneficial effect of renal transplantation on cognitive brain function.
Cognitive brain dysfunction is a common complication of end-stage renal disease.
To investigate the cerebral effect of renal transplantation, we studied ... Cited by 59 - Related articles - BL Direct - All 3 versions
- ►asnjournals.org [PDF] NR Powe, RI Griffiths, AJ Watson, GF … - Journal of the American Society of Nephrology, 1994 - Am Soc Nephrol Page 1. Journal of the American Society of Nephrology 1455 Effect of Recombinant
Erythropoietin on Hospital Admissions, Readmissions ... Cited by 37 - Related articles - BL Direct - All 4 versions
J LOIS, AE AYASH, GD MYLA HUNT, W … - British Journal ofHuematoZogy, 1994 - interscience.wiley.com Summary. Patients with solid tumours undergoing highdose chemotherapy with
autologous bone marrow transplantation use an average of 10 units of packed red
blood cells (PRBC) while awaiting haemopoietic reconstitution. They are ... Cited by 33 - Related articles - BL Direct - All 3 versions
A Braun, R Ding, C Seidel, T Fies, A Kurtz, K … - Pediatric Nephrology, 1993 - Springer Abstract. The single-dose pharmacokinetics of recombi- nant human erythropoietin
(rHuEPO) given SC was inves- tigated in 20 patients aged 7-20 years at different
stages of chronic renal failure. In a pilot study we confirmed the lower ... Cited by 25 - Related articles - BL Direct - All 3 versions
PF Finelli, MD Carley - Archives of Neurology, 2000 - Am Med Assoc Case Description A 37-year-old patient who was receiving peritoneal dialysis and
epoetin alfa (Epogen) therapy presented with a several-day history of worsening
headache, and a neuroimaging scan demonstrated thrombosis of the sagittal ... Cited by 23 - Related articles - BL Direct - All 5 versions
NR Powe, RI Griffiths, JW Greer, AJ Watson, … - Kidney international, 1993 - nature.com Early dosing practices and effectiveness of recombinant human erythropoietin. In
a national longitudinal-cohort study of 59,462 end-stage renal disease (ESRD)
patients, we examined dosing and effectiveness of erythropoietin (EPO) ... Cited by 21 - Related articles - BL Direct - All 3 versions